Vifor Pharma AG (Vifor Pharma AG) Net Income (Continuing Operations) : $291 Mil (TTM As of Dec. 2021)

View and export this data going back to 2013. Start your Free Trial

What is Vifor Pharma AG Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Vifor Pharma AG's Net Income (Continuing Operations) for the six months ended in Dec. 2021 was $90 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2021 was $291 Mil.

Vifor Pharma AG Net Income (Continuing Operations) Historical Data

The historical data trend for Vifor Pharma AG's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Net Income (Continuing Operations) Chart

Vifor Pharma AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Net Income (Continuing Operations)

Get a 7-Day Free Trial

125.63

246.40

226.75

267.45

288.17

Vifor Pharma AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Net Income (Continuing Operations)	Get a 7-Day Free Trial															98.51	93.14	167.72	200.82	90.23

Vifor Pharma AG Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was $291 Mil.

Vifor Pharma AG (OTCPK:GNHAF) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Vifor Pharma AG Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Vifor Pharma AG (Vifor Pharma AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (OTCPK:GNHAF) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rechenstrasse 37, Saint Gallen, CHE, 9014

Website

https://www.viforpharma.com

Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.